Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $179.19 | 10 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $46.73 | 3 | $0 (2019) |
| PFIZER INC. | $43.53 | 1 | $0 (2019) |
| GlaxoSmithKline, LLC. | $37.81 | 3 | $0 (2020) |
| SANOFI-AVENTIS U.S. LLC | $17.67 | 1 | $0 (2017) |
| Exact Sciences Corporation | $17.60 | 1 | $0 (2024) |
| Merck Sharp & Dohme Corporation | $15.85 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $17.60 | 1 | Exact Sciences Corporation ($17.60) |
| 2020 | $24.30 | 2 | GlaxoSmithKline, LLC. ($24.30) |
| 2019 | $76.33 | 3 | PFIZER INC. ($43.53) |
| 2017 | $60.96 | 4 | SANOFI-AVENTIS U.S. LLC ($17.67) |
All Payment Transactions
10 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/22/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $17.60 | General |
| Category: Oncology | ||||||
| 12/17/2020 | GlaxoSmithKline, LLC. | BEXSERO (Biological), SHINGRIX | Food and Beverage | In-kind items and services | $12.15 | General |
| Category: VACCINES | ||||||
| 04/30/2020 | GlaxoSmithKline, LLC. | BEXSERO (Biological) | Food and Beverage | In-kind items and services | $12.15 | General |
| Category: VACCINES | ||||||
| 10/01/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $11.82 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/13/2019 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $43.53 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 03/15/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $20.98 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/29/2017 | GlaxoSmithKline, LLC. | BEXSERO (Biological), BOOSTRIX, FLUARIX | Food and Beverage | In-kind items and services | $13.51 | General |
| Category: VACCINES | ||||||
| 08/01/2017 | SANOFI-AVENTIS U.S. LLC | SOLIQUA (Drug) | Food and Beverage | In-kind items and services | $17.67 | General |
| Category: DIABETES | ||||||
| 05/19/2017 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), JANUMET, JANUMET XR | Food and Beverage | In-kind items and services | $15.85 | General |
| Category: ENDOCRINOLOGY | ||||||
| 04/12/2017 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA | Food and Beverage | In-kind items and services | $13.93 | General |
| Category: Cardiovascular & Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 335 | 616 | $102,345 | $34,887 |
| 2022 | 6 | 361 | 460 | $84,865 | $14,350 |
| 2021 | 18 | 1,423 | 2,037 | $297,682 | $75,229 |
| 2020 | 21 | 1,529 | 2,315 | $362,296 | $74,108 |
All Medicare Procedures & Services
51 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 101 | 225 | $55,940 | $19,225 | 34.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 106 | 227 | $39,993 | $13,442 | 33.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 11 | 11 | $3,598 | $1,045 | 29.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 71 | 88 | $1,680 | $726.60 | 43.3% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 22 | 30 | $821.70 | $285.60 | 34.8% |
| 82950 | Blood glucose (sugar) level after receiving dose of glucose | Office | 2023 | 24 | 35 | $312.90 | $162.75 | 52.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 108 | 162 | $56,003 | $9,976 | 17.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 72 | 90 | $22,797 | $3,026 | 13.3% |
| 83037 | Hemoglobin a1c level, by device for home use | Office | 2022 | 64 | 73 | $3,588 | $705.63 | 19.7% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 19 | 19 | $1,188 | $318.60 | 26.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 74 | 90 | $993.20 | $265.89 | 26.8% |
| 81003 | Automated urinalysis test | Office | 2022 | 24 | 26 | $296.40 | $58.32 | 19.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 155 | 297 | $102,673 | $25,576 | 24.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 170 | 323 | $81,816 | $18,103 | 22.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 78 | 78 | $29,082 | $10,130 | 34.8% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 81 | 81 | $5,508 | $5,144 | 93.4% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 63 | 76 | $23,180 | $3,329 | 14.4% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2021 | 27 | 33 | $13,431 | $2,542 | 18.9% |
| G0444 | Annual depression screening, 15 minutes | Office | 2021 | 142 | 142 | $8,875 | $2,542 | 28.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 88 | 89 | $4,339 | $1,427 | 32.9% |
| 0001A | Adm sarscov2 30mcg/0.3ml 1st | Office | 2021 | 36 | 37 | $4,694 | $1,391 | 29.6% |
| G0442 | Annual alcohol misuse screening, 15 minutes | Office | 2021 | 77 | 77 | $4,558 | $1,378 | 30.2% |
| 83037 | Hemoglobin a1c level, by device for home use | Office | 2021 | 84 | 127 | $6,242 | $1,230 | 19.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 171 | 309 | $3,337 | $913.35 | 27.4% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time per calendar month | Office | 2021 | 14 | 30 | $4,518 | $609.27 | 13.5% |
About Dr. Gerald Robertson, MD
Dr. Gerald Robertson, MD is a Medical Oncology healthcare provider based in Gallup, New Mexico. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/02/2006. The National Provider Identifier (NPI) number assigned to this provider is 1831161082.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Gerald Robertson, MD has received a total of $179.19 in payments from pharmaceutical and medical device companies, with $17.60 received in 2024. These payments were reported across 10 transactions from 6 companies. The most common payment nature is "Food and Beverage" ($179.19).
As a Medicare-enrolled provider, Robertson has provided services to 3,648 Medicare beneficiaries, totaling 5,428 services with total Medicare billing of $198,574. Data is available for 4 years (2020–2023), covering 51 distinct procedure/service records.
Practice Information
- Specialty Medical Oncology
- Location Gallup, NM
- Active Since 02/02/2006
- Last Updated 07/09/2007
- Taxonomy Code 207RX0202X
- Entity Type Individual
- NPI Number 1831161082
Products in Payments
- XARELTO (Drug) $46.73
- ELIQUIS (Drug) $43.53
- BEXSERO (Biological) $37.81
- SOLIQUA (Drug) $17.67
- Cologuard Collection Kit (Device) $17.60
- JANUVIA (Drug) $15.85
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.